ValuentumAd

Official PayPal Seal














Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Aug 6, 2014
M&A Environment Cracks: Sprint and Fox
Management teams are subject to the same behavioral pitfalls as investors: wheeling and dealing when the times are good; running for the hills when times are bad. Sprint and Fox Entertainment reminded us today of the many pitfalls to which management teams can succumb.
Aug 5, 2014
Big Oil Round Up: Earnings Portal
Let’s put together the calendar second-quarter reports from the oil & gas majors.
Aug 4, 2014
Dividend Increases for the Week Ending August 1
Let's take a look at dividend increases for the week ending August 1.
Aug 2, 2014
Valuentum's August Edition of Its Dividend Growth Newsletter!
The August edition of our Dividend Growth Newsletter is now available.
Aug 1, 2014
Procter & Gamble Wraps Up a Strong Fiscal Year 2014
The Dividend Growth portfolio holding continues to deliver on financial goals.
Aug 1, 2014
Markets Collapse: Economic Sanctions on Russia, Argentina Defaults…Again
Dow Jones falls over 300 points Thursday on Argentina default and economic sanctions on Russia. The very idea that we don’t know which hedge funds will be hurt by recent global economic activity, how leveraged these hedge funds are to global currencies and equities, and whether Russian president Vladimir Putin will respond in kind to economic sanctions means conservative investors are taking money off the table. Is it finally time to lock in profits after one of the best stock-market runs of all time from the March 2009 lows?
Jul 31, 2014
Union Pacific Still on Track
The railroad’s performance continues to align with our investment thesis.
Jul 31, 2014
Teva: Progressing As Expected; US Generic Revenue Reveals Strength
The generics pharma giant has been one of the best performing stocks during 2014, up nearly 34% year-to-date.
Jul 31, 2014
PPL Beats Expectations and Raises Guidance
PPL continues to be one of our favorite ideas in the utility space.
Jul 30, 2014
Big Pharma Round Up
Let’s take a look at recent quarterly results from Big Pharma.



The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.